Biomedical Engineer | BFS Line Technician at Nephron Pharmaceuticals Corporation | Former Naval Nuclear Reactor Operator | MBA Candidate | FINRA SIE & Series 6
Joined April 2010
- Tweets 2,627
- Following 430
- Followers 15,659
- Likes 33,843
4 Photos and videos
Pinned Tweet
Mar 14
I’m excited to join Nephron Pharmaceuticals and continue my work in biomedical engineering within the FDA cGMP pharmaceutical manufacturing space.
linkedin.com/posts/kylelacio…
1
3
508
Apr 16
RT @WSJ: Today, fewer than 200 humanoid robots are in the world’s factories. Up to 5 million could be in place by 2040.
424
Kyle Lacio retweeted
Join us for 'Advanced Training in Sterile Compounding Essentials for Designated Persons,’ August 27-28, 2026.
💡 20-hour ACPE-accredited program includes home study hands-on training in our ACE Lab in Columbia, SC
Register by August 13 ➡️ bit.ly/4tAgjof
1
2
2
160
Kyle Lacio retweeted
Apr 14
Big news for innovators, founders, and R&D-driven small companies: NIH’s Seed Fund is back in action!
Thanks to new legislation, U.S. small businesses are again able to pursue up to $1.4 billion per year in Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding to power breakthrough science, build game-changing technologies, and move solutions toward real-world impact.
Start planning by checking out the funding opportunity forecasts on Grants.gov.
➡️Funding opportunity forecasts: bit.ly/4ccHkIR
📌Key resources for applicants: bit.ly/3OkyeAA
ALT The image announces "NIH's Seed Fund is Back!" with more than $1.4B available in fiscal year 2026. It features logos for America's Seed Fund and the National Institutes of Health. Test tubes are in the background, and a pipette is shown above them.
9
46
225
66,035
Apr 11
OpenAI Foundation's $100M Alzheimer's grant initiative:
1. Causal map of Alzheimer's
2. AI drug design & lab validation
3. Open datasets to predict drug activity
4. New biomarkers for diagnosis
5. Anonymized patient data review for off label treatments
openaifoundation.org/news/ai…
91
Kyle Lacio retweeted
🚀 The largest-ever open‑source protein‑complex treasure trove - 1.7 million of AI‑predicted complexes now live in the AlphaFold Database
In collaboration with @emblebi, @GoogleDeepMind, and @SeoulNatlUni, we have added millions of predicted complexes to the AlphaFold Database to accelerate global health research.
🧵👇
13
132
711
58,820
Kyle Lacio retweeted
Over 200 active drug shortages in the U.S. right now. Sterile injectables are hit hardest.
Nephron runs 24/7/365 in West Columbia, SC — over $500M invested, 840,000 sq ft, 1B doses/year — because patients cannot wait.
#DrugShortage #AmericanManufacturing #NephronPharma
1
2
112
Apr 8
Nature featured brain organoids. I grew them. Spent 2 years in Dr. Daping Fan's lab developing a pilot iPSC-derived 3D organoid program for Alzheimer's drug testing. 3D organoids are a much closer model than mice or cell culture. Expect to see more of this in future research.
Lab-grown organoids are turbo-charging the study of human brain development and disease
go.nature.com/41SFsia
2
349
Kyle Lacio retweeted
Very true - it's time to call for a Human Cell Project, analogous to the Human Genome Project, to systematically and comprehensively characterize and model first the simplest and then the most complex cells. A moonshot to catapult biology to the next era🦠🚀💪 - let's go!!
Really enjoyed @NatureBiotech's new commentary "Minimal life by computer": the road to a true virtual cell is not just bigger AI models.
It’s AI mechanistic biology.
Pattern recognition can get you far. But if we want to simulate life, predict interventions, and actually understand cells, we need models with causal structure beyond just correlations.
paper: nature.com/articles/s41587-0…
10
33
157
25,399
Kyle Lacio retweeted
America relies on China for up to 90% of key drug ingredients—putting our supply and national security at risk. We must rebuild U.S. manufacturing, boost innovation, and confront this challenge head-on to keep lifesaving medicines made in America.
72
72
257
42,022
We're going farther than ever before 🚀
Today, the Artemis II crew will break the record for how far humans have traveled from Earth as they fly around the far side of the Moon.
Coverage begins at 1 p.m. EDT (1700 UTC). Watch Artemis II make history: nasa.gov/ways-to-watch/
1,705
13,359
64,007
3,583,977
Kyle Lacio retweeted
Apr 4
What's bigger, GLP1s or AI?
Apr 3
Semaglutide alone (one single peptide) generated $34.6 billion in sales in 2025. OpenAI hit $20B revenue that year.
So a single peptide out-earned ChatGPT by 1.7x. And that's before Eli Lilly's tirzepatide, which added another $25B.
6
39
173
114,623
Apr 5
Astronauts posting on Twitter on the way to the moon. This is so exciting. We're going back to the moon!
1
110
Kyle Lacio retweeted
FDA approves GLP-1 pill for obesity nature.com/articles/d41573-0…
Eli Lilly’s orforglipron is the first small-molecule GLP-1 receptor agonist to secure approval, offering a potential convenience edge over established peptidic GLP-1-based obesity drugs
1
32
82
4,965
Apr 5
This study showed antithymocyte globulin (ATG) was able to suppress the autoimmune destruction of the pancreas in newly diagnosed children age 5-25 with Type 1 diabetes. Protecting insulin producing function.
thelancet.com/journals/lance…
303
Kyle Lacio retweeted
Sickle cell disease affects thousands of Americans.
With new gene therapies offering real hope, I’m urging the FDA to revisit a decision denying a Priority Review Voucher for a curative therapy. We need policies that encourage innovation and give patients access to life-saving treatments! scott.senate.gov/media-cente…
52
12
75
7,813
Apr 4
PK/PD (Pharmacokinetics/Pharmacodynamics) modeling integrates how the body processes a drug (PK: absorption, distribution, metabolism, excretion) with the drug’s biological effect on the body (PD: efficacy, toxicity).
69
This Startup Wants To Use Mini Robots To Treat Alzheimer's
MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.
Read more: forbes.com/sites/amyfeldman/…
1
10
25
15,260
Kyle Lacio retweeted
Q1 done.
We didn't take a day off.
We never do.
24/7/365 from West Columbia, SC. 🇺🇸
#NephronPharma #AmericanManufacturing #MadeInUSA
1
5
213
Mar 31
In The Design of Everyday Things, Don Norman explains that when something is confusing, it’s usually because the design is bad not because the user did something wrong.
Good engineering is easy to understand right away.
Bad engineering makes people feel confused or frustrated.
1
45
Mar 31
A nebulizer is a medical device that turns liquid medication into a fine mist so it can be easily inhaled into the lungs. A mask is often used until the child is about 6 years old.
71